Microscopic extensions of head and neck squamous cell carcinomas: Impact for CTV definition;Approche anatomopathologique de l'extension microscopique des carcinomes épidermoïdes ORL: Implications pour la définition du volume cible anatomoclinique

Cancer/Radiotherapie

Volumn 18, Issue 7, 2014, Pages 666-671

  Fleury, B ^a   Thariat, J ^b   Barnoud, R ^c   Buiret, G ^d   Lebreton, F ^c   Bancel, B ^c   Poupart, M ^c   Devouassoux Shisheboran, M ^c  

^a Centre Marie Curie   (France)

^b CENTRE ANTOINE LACASSAGNE   (France)

^c CROIX ROUSSE HOSPITAL   (France)

^d CENTRE HOSPITALIER DE VALENCE   (France)

Author keywords

Conformal radiotherapy; Head and neck squamous cell carcinomas; Histology; Target volumes

Indexed keywords

ADVANCED CANCER; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SIZE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; MICROSCOPIC ANATOMY; ONCOLOGICAL PARAMETERS; PRIORITY JOURNAL; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; HEAD AND NECK NEOPLASMS; MALE; MICROSCOPY; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; STAINING; TUMOR INVASION;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MICROSCOPY; MIDDLE AGED; NEOPLASM INVASIVENESS; PROSPECTIVE STUDIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; STAINING AND LABELING;

EID: 84922902038     PISSN: 12783218     EISSN: 17696658     Source Type: Journal    
DOI: 10.1016/j.canrad.2014.04.006     Document Type: Article

References (26)

1. Dawson L.A., Anzai Y., Marsh L., Martel M.K., Paulino A., Ship J.A., et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2000, 46:1117-1126.
2. Nutting C.M., Morden J.P., Harrington K.J., Urbano T.G., Bhide S.A., Clark C., et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3multicentre randomised controlled trial. Lancet Oncol 2011, 12:127-136.
3. Eisbruch A., Foote R.L., O'Sullivan B., Beitler J.J., Vikram B. Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets. Semin Radiat Oncol 2002, 12:238-249.
4. Hansen E.K., Bucci M.K., Quivey J.M., Weinberg V., Xia P. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2006, 64:355-362.
5. Lee N., Xia P., Fischbein N.J., Akazawa P., Akazawa C., Quivey J.M. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys 2003, 57:49-60.
6. Bidault F.J., Bourhis J., Luboinski B. Établissement des volumes cibles anatomocliniques. Cancer Radiother 2005, 9:271-279.
7. Fleury B., Biston M.C., Montbarbon X., Pommier P. Cancers du cavum de l'adulte. Cancer Radiother 2010, 14:S23-S33.
8. Guerrero Urbano M.T., Clark C.H., Kong C., Miles E., Dearnaley D.P., Harrington K.J., et al. Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelines. Clin Oncol 2007, 19:604-613.
9. Lapeyre M., Henrot P., Alfonsi M., Bardet E., Bensadoun R.J., Dolivet G., et al. Proposition de sélection et délimitation des volumes cibles microscopiques péritumoraux dans les cancers de la cavité buccale et de l'oropharynx (aires ganglionnaires exclues). Cancer Radiother 2005, 9:261-270.
10. Chao K.S., Ozyigit G., Tran B.N., Cengiz M., Dempsey J.F., Low D.A. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2003, 55:312-321.
11. Lapeyre M., Toledano I., Bourry N., Bailly C., Cachin F. Délinéation des volumes cibles des cancers des voies aérodigestives supérieures en radiothérapie conformationnelle avec modulation d'intensité. Cancer Radiother 2011, 15:466-472.
12. Lapeyre M., Loos G., Biau J. Délinéation des cancers de la cavité buccale et de l'oropharynx. Cancer Radiother 2013, 17:493-497.
13. Expert Panel on Radiation O-H, Neck, Salama J.K., Saba N., Quon H., Garg M.K., et al. ACR appropriateness criteria(R) adjuvant therapy for resected squamous cell carcinoma of the head and neck. Oral Oncol 2011, 47:554-559.
14. Campbell S., Poon I., Markel D., Vena D., Higgins K., Enepekides D., et al. Evaluation of microscopic disease in oral tongue cancer using whole-mount histopathologic techniques: implications for the management of head-and-neck cancers. Int J Radiat Oncol Biol Phys 2012, 82:574-581.
15. Davidson T.M., Haghighi P., Astarita R., Baird S., Seagren S. Microscopically oriented histologic surgery for head and neck mucosal cancer. Cancer 1987, 60:1856-1861.
16. Meier J.D., Oliver D.A., Varvares M.A. Surgical margin determination in head and neck oncology: current clinical practice. The results of an International American Head and Neck Society Member Survey. Head Neck 2005, 27:952-958.
17. McMahon J., O'Brien C.J., Pathak I., Hamill R., McNeil E., Hammersley N., et al. Influence of condition of surgical margins on local recurrence and disease-specific survival in oral and oropharyngeal cancer. Br J Oral Maxillofac Surg 2003, 41:224-231.
18. Batsakis J.G. Surgical excision margins: a pathologist's perspective. Adv Anat Pathol 1999, 6:140-148.
19. Loree T.R., Strong E.W. Significance of positive margins in oral cavity squamous carcinoma. Am J Surg 1990, 160:410-414.
20. Bernier J., Domenge C., Ozsahin M., Matuszewska K., Lefebvre J.L., Greiner R.H., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004, 350:1945-1952.
21. Cooper J.S., Pajak T.F., Forastiere A.A., Jacobs J., Campbell B.H., Saxman S.B., et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004, 350:1937-1944.
22. Daisne J.F., Duprez T., Weynand B., Lonneux M., Hamoir M., Reychler H., et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 2004, 233:93-100.
23. Giraud P., Antoine M., Larrouy A., Milleron B., Callard P., De Rycke Y., et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 2000, 48:1015-1024.
24. Lafond C., Pointreau Y., Debelleix C., Denis F., Calais G., Bourhis J., et al. Cancer de l'oropharynx. Cancer Radiother 2010, 14:S34-S42.
25. Lapeyre M., Bailly C., Toledano I., Montalban A., Russier M. Cancer de l'hypopharynx et du larynx: proposition de sélection et délimitation des volumes cibles microscopiques péritumoraux (aires ganglionnaires exclues). Cancer Radiother 2010, 14:S43-S51.
26. Johnson R.E., Sigman J.D., Funk G.F., Robinson R.A., Hoffman H.T. Quantification of surgical margin shrinkage in the oral cavity. Head Neck 1997, 19:281-286.